New pterostilbene ingredient claimed to be superior to resveratrol

By Guy Montague-Jones

- Last updated on GMT

Related tags: Ceo frank jaksch, Clinical trial, Chromadex

ChromaDex is launching an ingredient with similar properties to resveratrol having obtained commercial rights to the biological compound from the University of Mississippi and the Agriculture Research Service (ARS).

Found in blueberries, grapes, and other small fruits, pterostilbene is the name of the compound that ChromaDex is launching under the pTeroPure brand.

Health benefits

Pterostilbene is chemically related to resveratrol, and according to ChromaDex, it has shown promise for improving cardiovascular health, glucose levels, and cognitive function.

ChromaDex CEO Frank Jaksch told that the company has licensed patents related to cholesterol control, diabetes, and oxidative stress.

Comparing pterostilbene to resveratrol, Jaksch said they are very similar but the former has the advantage of metabolising at a slower rate in the body giving it more opportunity to be absorbed into the blood stream.

ChromaDex said research also indicates that the two can work well together and may be more effective in combination than as separate entities. Jaksch said research suggests that one picks up where the other falls down and visa versa.

Initially ChromaDex will be targeting the dietary supplement market in the US but there are plans eventually expand into the functional food and drink space. In preparation for this next step the California-based company is planning to complete its first clinical trial on pterostilbene by the end of the year and work on the development of a water soluble version of the ingredient.

Research history

Research on the properties and potential of pterostilbene has been conducted by a group of scientists at the University of Mississippi and the ARS – a scientific research arm of the US Department of Agriculture.

ARS researcher Agnes Rimando began work on the compound in the 1990s when the health benefits of resveratrol were being discovered.

Ricardo wanted to discover whether pterostilbene offered similar benefits and so in 2003 she collaborated with other scientists including Dennis Feller, the former chair of pharmacology at the University of Mississippi.

Related news

Show more

Related products

show more

The Year of

The Year of "Destination Health" Has Arrived

Blue California | 01-Apr-2022 | Infographic

Consumers are pursuing prevention over cure as the ticket to long-term health and wellness. While immunity is at the forefront of health, consumers are...

curcuRouge, the uncompromising bioavailability

curcuRouge, the uncompromising bioavailability

ROBERTET - Food and Nutra | 24-Mar-2022 | Technical / White Paper

While the market has long been driven by a quest for bioavailability, sometimes at the expense of products quality, it now seems to shift toward more naturality...

Related suppliers

Follow us


View more